In the first such clinical trial in the United States, physician-scientists with the University of Maryland School of Medicine (UMSOM) are investigating the use of magnetic resonance imaging (MRI)-guided focused ultrasound to open the blood-brain barrier. The trial will be conducted with patients undergoing brain cancer surgery at the University of Maryland Medical Center (UMMC).
HealthMyne announced the release of Quantitative Imaging Decision Support (QIDS) 5 featuring a new, automated Cancer Screening Module. The module is designed for tracking, communicating and reporting on patients who may be at a higher risk for developing cancer.
At the Association for Medical Imaging Management (AHRA) 2018 Annual Meeting and Exposition, July 22-25 in Orlando, Fla., Nuance Communications Inc. announced the general availability of a cloud-based version of its mPower Clinical Analytics platform for radiology.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
August 15, 2018 — Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening ...
Intel and Philips recently tested two healthcare uses for deep learning inference models using Intel Xeon Scalable processors and the OpenVINO toolkit. One use case focused on X-rays of bones for bone-age-prediction modeling, the other on computed tomography (CT) scans of lungs for lung segmentation. In these tests, Intel and Philips achieved a speed improvement of 188 times for the bone-age-prediction model, and a 38 times speed improvement for the lung-segmentation model over the baseline measurements.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Fujifilm SonoSite Inc. announced the launch of two new transducers for the SonoSite iViz point-of-care ultrasound, now connecting a total of four to their handheld diagnostic tool. Now with the addition of the L25v and C60v transducers to its portfolio, the iViz enables clinicians to view superficial applications such as ophthalmic, arterial, venous, lung and nerve, as well as deeper applications such as abdominal and obstetrics.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
I attended the American Association of Physicists in Medicine (AAPM) 2018 meeting in late July and came back with many takeaways.
August 14, 2018 — Guerbet LLC USA announced a commercial partnership with Imalogix, a provider of artificial ...
Haojie Wang, M.D., director of advanced cardiovascular MRI and a member of the heart valve clinic at Baylor Scott White ...
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018 making Illinois the 36th state to report dense breast tissue to patients. It became the fifth state to enact a breast density law in 2018, joining Utah, Washington, Florida and Wisconsin.
ITN Editor Dave Fornell takes a tour of some of the innovative new technologies on the expo floor at the 2018 American ...
August 13, 2018 — The American College of Radiology Liver Imaging Reporting and Data System (LI-RADS) steering committee ...
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
A discussion with Mahadevappa Mahesh, Ph.D., FAAPM, FACR, FACMP, FSCCT, professor of radiology and cardiology and chief ...
A discussion with Matthew Freeman, Ph.D., scientist at Los Alamos National Laboratory, New Mexico. He spoke about his ...
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Exact Imaging announced that it has become a UroGPO Imaging Partner, joining the North American urology-specific group purchasing and service organization. As an Imaging Partner, Exact Imaging’s ExactVu micro-ultrasound platform for targeted prostate biopsies will now be available to UroGPO’s 550-plus member urology practices as part of the UroGPO suite of offerings.
Patients in Pulaski County, Ind., now have access to quiet, comfortable magnetic resonance (MR) exams thanks to the installation of the Vantage Titan/Zen Edition 1.5T from Canon Medical Systems USA Inc. at Pulaski Memorial Hospital. Pulaski Memorial, a critical access facility that was previously using a mobile unit to conduct MR exams, is the first healthcare provider in the U.S. to install the system. The facility is leveraging the system to conduct musculoskeletal (MSK) and neuro exams, as well as expand its abdominal imaging capabilities.
The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule August 9 that would overhaul the Medicare Shared Savings Program established by the Affordable Care Act and launched in 2012. The Medicare Shared Savings Program is the umbrella under which the vast majority of Medicare’s Accountable Care Organizations (ACOs) operate. The redesigned program is called Pathways to Success.
Visage Imaging Inc. announced that it has signed a seven-year contract with Mercy, the fifth largest Catholic health system in the U.S., for Visage 7 Open Archive. Visage 7 Open Archive is a core module of the Visage 7 Enterprise Imaging Platform, closely coupling the open storage of medical images and multimedia to Visage 7.
A discussion with Martin Vallieres, Ph.D., post-doctoral fellow at McGill University, Montreal, Canada. He spoke on this ...
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the metastases. However, little is known about ER expression across metastases throughout the body and surrounding normal tissue. Using a positron emission tomography (PET) tracer, researchers in the Netherlands have been able to identify differences in ER expression, which could help guide treatment for metastatic breast cancer patients. The study is featured in The Journal of Nuclear Medicine’s August issue.